Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences and member-exclusives.

Talking Techniques | Paul Brennan: repairing nerve damage and addressing Alzheimer’s

Diagnostics and preclinical Molecular biology

In this episode BioTechniques Digital Editor, Tristan Free, speaks to Paul Brennan, President and CEO of NervGen (BC, Canada), about the company’s new technique, currently under development, for repairing nerve damage and it’s potential for treating Alzheimer’s. Paul also covers some of the gaps in Alzheimer’s research and wades in on the Tau vs Amyloid Beta debate.